Cyclerion Therapeutics, Inc. financial statements
Cyclerion Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 2.07M | EODHD |
| Net income | −USD 3.53M | EODHD |
| Cash and equivalents | USD 3.24M | EODHD |
Cyclerion Therapeutics, Inc. financials on 6ix · Cyclerion Therapeutics, Inc. on 6ix